Clinical Trials Directory

Trials / Completed

CompletedNCT01974804

Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Magnetic resonance imaging (MRI) is a diagnostic study that makes pictures of organs of the body using magnetic field and radio frequency pulses that can not be felt. The purpose of this study is to determine if new imaging methods can help tumor evaluation in the brain. The extra images will be obtained using diffusion and perfusion MRI techniques to assess early treatment response in patients with brain metastasis, and will be compared to methods currently being used.

Conditions

Interventions

TypeNameDescription
PROCEDUREMRI

Timeline

Start date
2013-10-25
Primary completion
2022-12-28
Completion
2022-12-28
First posted
2013-11-04
Last updated
2022-12-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01974804. Inclusion in this directory is not an endorsement.

Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis (NCT01974804) · Clinical Trials Directory